Let's Talk OAB

Release Date: Friday, December 26, 2014 Expiration Date: Saturday, December 26, 2015

Program Overview

Overactive bladder (OAB) is a chronic, debilitating condition that impacts approximately 34 million Americans. Though OAB is a common condition, it is estimated that less than 30% of patients receive treatment, likely attributed to the reluctance of patients to talk to their healthcare providers about the condition. Left untreated, OAB can significantly impact a patient’s quality of life, including physical, psychological, social, domestic, occupational, and sexual aspects. The economic cost of OAB is also staggering, estimated at nearly $66 billion annually in the US.

To improve patient quality of care and satisfaction, clinicians should take a proactive approach to screen patients and provide education regarding OAB. This should include information about normal lower urinary tract function, what is known about OAB, the benefits vs. risks/burdens of the available treatment options, and the importance of adherence to treatment. It is also essential for clinicians to educate their patients on expected outcomes from current therapeutic options and develop realistic patient-centered goals for treatment.

As the science relevant to OAB evolves and improves, and the literature continually expands, PCPs must stay up-to-date on new treatment strategies and therapeutic options. With the implementation of the Affordable Care Act, many who were previously uninsured will now pursue medical assistance to manage long-standing signs and symptoms. Often-times, the first provider-patient contact will be with a PCP, who will be in an ideal position to screen, diagnose and treat patients with OAB. This program presents the latest clinical data on the identification and management of patients suffering from OAB.

Target Audience

This educational initiative is designed as a comprehensive approach to address the practice needs of primary care providers, including primary care physicians, doctors of osteopathy, physician assistants, nurse practitioners, and allied healthcare professionals, who are at the forefront of caring for adult patients who may be suffering from OAB.

Learning Objectives

Upon completing this program, participants will be able to:

Identify patients with OAB through screening and appropriate diagnostic techniques
Evaluate current treatment options to individualize therapy based on effectiveness and adverse event profile
Implement strategies to regularly assess patient satisfaction with OAB treatment and adjust therapy when necessary to improve effectiveness and adherence

Educational Format

These Online Presentations are based on a 2014 primary care OAB program series. This online activity is divided into three portable and easy to access episodes:

EPISODE 1:
The Nurse Practitioner Perspective
Screening, Diagnostic Techniques and Nonpharmacologic Management

EPISODE 2:
The Primary Care Perspective
Early Recognition, Diagnosis, and Management

EPISODE 3:
The Urologist Perspective
Utilizing Current Pharmacologic Options to Attain Treatment Goals

Faculty

	David A. Ginsberg, MD Associate Professor of Clinical Urology Department of Urology Keck School of Medicine University of Southern California Los Angeles, CA Chief of Urology Rancho Los Amigos National Rehabilitation Center Downey, CA

	Diane K. Newman, DNP, FAAN, BCB-PMD Adjunct Professor of Urology in Surgery Research Investigator Senior Perelman School of Medicine, University of Pennsylvania Co-Director, Penn Center for Continence and Pelvic Health Division of Urology, University of Pennsylvania Medical Center Philadelphia, PA

	Matt T. Rosenberg, MD Director Mid Michigan Health Centers Department of Family Medicine, Allegiance Health Systems Jackson, Michigan

ACCREDITATION
Physicians

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Center for Independent Healthcare Education and Vemco MedEd, LLC. Center for Independent Healthcare Education (Center) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Center for Independent Healthcare Education designates this Enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
AAPA accepts AMA PRA Category 1 Credit™ for the PRA from organizations accredited by ACCME.

Nurse Practitioners
Nurse Practitioners will receive certificate of AMA PRA Category 1 Credit™ as this is an ACCME accredited program and its accreditation is recognized by Nurse Practitioner boards.

For questions regarding accreditation, please contact info@jointsponsor.com

Method of Participation and Instruction for Credit

Review the entire CME information including target audience, learning objectives, and disclosures.
Review each episode.
Complete the Online Post Test, Evaluation, and Credit Application form
Please note that to receive credit you must achieve a score of at least 70%.
Certificate of Credit will be emailed within 4 weeks of successful completion of the activity.

DISCLOSURE OF CONFLICTS ON INTEREST
In accordance with policies set forth by the Accreditation Council for Continuing Medical Education (ACCME), Center for Independent Healthcare Education requires all faculty members and spouses/significant others with an opportunity to affect the content of a continuing education activity to disclose any relevant financial relationships during the past 12 months with commercial interests. A commercial interest is any entity producing, marketing, reselling or distributing health care goods or services consumed by or used on patients. Relationships with commercial interests and conflicts of interest resulting from those relationships must be revealed to the audience and resolved prior to the activity

Relevant relationships include roles such as speaker, author, consultant, independent contractor (including research), employee, investor, advisory committee member, board member, review panelist, and investigator. If a potential speaker or author indicates a possible conflict of interest, the conflict will be resolved by choosing another speaker or author for that topical area, or the slides, handouts, and/or monograph will be reviewed and approved by a qualified commercially-disinterested peer.

PLANNING COMMITTEE MEMBERS
David A. Ginsberg, MD
Diane K. Newman, DNP
Matt T. Rosenberg, MD
Marco Cicero, PhD
Maja Drenovac, PharmD
Paul DeLisle

DISCLOSURE OF FINANCIAL INTEREST SUMMARY

David A. Ginsberg, MD (faculty/planner) has relevant financial relationships with commercial interests:
            Advisory Board: Allergan
            Consultant: Allergan
            Grant Recipient/Research Support: Allergan and Medtronic

Dr. Ginsberg does not discuss the off-label use of a product.

Diane K. Newman, DNP (faculty/planner) has relevant financial relationships with commercial interests:
            Advisory Board: Wellspect and Hollister
            Consultant: Bard, Uroplasty, and SRS Medical
            Grant Recipient/Research Support: Astellas to University of Pennsylvania

Dr. Newman does not discuss the off-label use of a product.

Matt T. Rosenberg, MD (faculty/planner) has relevant financial relationships with commercial interests:
Advisory Board and Consultant: Astellas Pharma, Pfizer, and Lilly
Speaker’s Bureau: Astellas Pharma

Dr. Rosenberg does not discuss the off-label use of a product.

No other speakers, authors, planners or content reviewers have any relevant financial relationships to disclose. No other speakers or authors will discuss off-label use of a product.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Fee
There is no fee to participate in this activity.

Hardware/Software Requirements
Microsoft Internet Explorer, Mozilla Firefox, Apple Safari or Google Chrome with the QuickTime Plug-in
Note: Please disable any “pop-up blocker” features.

Software/Hardware
Adobe® Reader version 7 or above to view PDF files (If you do not have Adobe® Reader, you can download it for free from Adobe.com)
Adobe Flash Player version 10 or above to view multimedia content (If you do
not have Adobe Flash Player, you can download it for free from Adobe.com)

Connection Speed
Cable, DSL, or better of at least 300 kbps

System Check
Please e-mail any questions or concerns to info@vemcomeded.com.

Privacy Policy

http://www.vemcomeded.com/privacy.asp

Joint Providership
This activity is jointly provided by Center for Independent Healthcare Education and Vemco MedEd.

Commercial Support
This activity is supported by an educational grant from
Astellas Scientific and Medical Affairs, Inc.

START ACTIVITY
By clicking on an episode below, I acknowledge that I have read the entire CME information.